U.S. Biotech Stock News

Thermo Fisher Scientific (NYSE:TMO) has entered into a data collaboration with Datavant to link real world data with its clinical research operations. The partnership uses Datavant's privacy preserving technology to connect diverse healthcare datasets for clinical studies. The goal is to support study design, patient recruitment, and evidence generation across life sciences research. Thermo Fisher Scientific, trading at $510.93, sits in a challenging period for shareholders, with the stock...

Voya Financial (VOYA) has launched a new fixed income offering of senior, unsecured fixed rate notes, shortly after filing an omnibus shelf registration that covers debt, equity, preferred stock, depositary shares, warrants, and units. See our latest analysis for Voya Financial. Voya’s new notes come after a period where momentum has softened slightly in the short term, with a 30 day share price return of a 1.83% decline. The 1 year total shareholder return of 6.56% and 5 year total...

Barrick Mining (NYSE:B) is preparing an IPO of its North American gold assets. The company has not yet confirmed the final structure or timing of the transaction. The move would separate a key regional gold portfolio into a new publicly traded vehicle. The planned IPO comes with Barrick Mining shares at $47.96 and a very large 1 year return and strong multi year gains, including 221.0% over 3 years and 194.9% over 5 years. For existing shareholders, carving out the North American gold...

JPMorgan Chase (NYSE:JPM) confirmed it closed bank accounts held by former President Donald Trump and his businesses after the January 6, 2021 US Capitol events. New court filings in an ongoing lawsuit allege the closures were politically motivated, while the bank cites reputational risk considerations. The case brings fresh attention to how one of the largest US banks handles high profile clients when legal, political and reputational issues intersect. For you as an investor, this puts a...

If you are wondering whether TopBuild is still good value after a strong run, this article will walk through what the current share price could mean for you as an investor. The stock closed at US$518.92, with returns of 6.3% over the last 30 days, 20.3% year to date and 70.8% over 1 year. The 7 day return of a 5.8% decline may have some investors reassessing the balance between opportunity and risk. Recent coverage has focused on TopBuild as a key player in building products and installation...

If you are wondering whether Regeneron Pharmaceuticals is still priced fairly after a strong multi year run, or if the market is missing something in plain sight, this article will help you weigh what you are really paying for. The stock most recently closed at US$779.67, with returns of 3.5% over 30 days and 74.2% over 5 years, so recent moves and longer term performance give mixed signals on how the market is pricing its potential and risks. Recent headlines around Regeneron have focused...

Liberty Global Ltd. has reported its full-year 2025 results, with sales rising to US$4,878.5 million from US$4,341.9 million, but swinging from a net income of US$1.59 billion to a very large net loss of US$7.14 billion and a basic loss per share from continuing operations of US$20.86. The combination of higher revenue and a very large reported loss raises questions about cost structure, one-off charges, and how resilient the business model really is. We’ll now consider how this sharp move...

Snap (NYSE:SNAP) is shifting more of its revenue mix toward higher margin subscriptions, aiming for a larger base of recurring income. The company has spun off its Specs augmented reality glasses team into a subsidiary and senior executive Scott Myers, who was central to the project, has left. Snap is facing new regulatory and reputational pressure after the Texas Attorney General filed a lawsuit over alleged addictive features and mature content on its platform. Snap comes into these...

In February 2026, Airbnb reported fourth-quarter 2025 revenue of US$2,778 million and net income of US$341 million, with full-year 2025 revenue of US$12.24 billion and net income of US$2.51 billion, alongside completing share repurchases totaling US$6.47 billion across two programs. The company paired these results with a new US$2.32 billion shelf registration for employee share offerings and highlighted product initiatives like Reserve Now, Pay Later and transparent pricing as key drivers...

Insmed (INSM) has been in focus after its fourth quarter and full year 2025 earnings, where strong revenue from ARIKAYCE and new drug BRINSUPRI contrasted with a wider net loss and ambitious 2026 sales guidance. See our latest analysis for Insmed. Insmed’s recent earnings and guidance have come alongside a sharp move in the share price, with a 10.86% 7 day share price return and 5.57% 30 day share price return partly offsetting a 21.10% 90 day share price decline. The 1 year total shareholder...

If you are wondering whether CONMED's current share price reflects its true worth, this article walks through the key signals that matter for value focused investors. The stock last closed at US$45.14, with a recent return of 8.0% over 7 days and 8.4% over 30 days, set against an 11.4% return year to date and a 25.4% decline over the past year. These moves sit against a backdrop of ongoing interest in medical devices and surgical technologies. Investors are watching how companies like CONMED...

If you are wondering whether Qiagen's current share price offers fair value or a potential gap to fundamentals, you are in the right place. The stock last closed at US$48.57, with returns of 22.1% over 1 year and 2.1% year to date. Over the past week and 30 days it saw declines of 3.7% and 12.7% respectively, which may have changed how the market views its risk and opportunity. Recent news flow around Qiagen has mainly focused on its role in molecular diagnostics and life sciences tools,...

What Ascendis Pharma’s Recent Trading Signals Tell You Ascendis Pharma (NasdaqGS:ASND) has drawn attention after recent trading left the share price around $225, with a modest gain over the past week but a small decline over the past month. For context, the stock shows a positive total return over the past 3 months and past year. Longer multiyear returns and current fundamentals such as revenue, net income, and valuation metrics shape how some investors are reassessing the risk and reward...

American Water Works Company (NYSE:AWK) and Essential Utilities shareholders have overwhelmingly approved an all stock, tax free merger. The combined company will operate under the American Water name and is expected to become the largest regulated water and wastewater utility in the United States. The merger is targeted to close by the end of Q1 2027, subject to regulatory approvals across the involved jurisdictions. For you as an investor following NYSE:AWK, this vote is a key corporate...

If you are wondering whether Corcept Therapeutics at around US$34.82 is starting to look interesting on price, you are not alone. The stock has been drawing attention from investors focused on value. The share price has seen a 12.9% decline over the last 7 days, 20.8% over 30 days, 8.8% year to date and 45.2% over 1 year, even though the 3 year and 5 year returns sit at 63.4% and 38.4% respectively. Recent coverage has largely centered on ongoing developments in its pharmaceutical and...

Quantum Computing Inc. (NasdaqCM:QUBT) has acquired Luminar Semiconductor, adding integrated photonics capabilities to its quantum computing portfolio. The company is shifting its growth focus toward integrated photonics based architectures for quantum information processing. Quantum Computing Inc. is also expanding its contracts with the United States Department of Defense, increasing its exposure to government and defense related work. For you as an investor, this move puts Quantum...

The Trump administration’s move to impose a 15% global tariff for up to 150 days immediately put Flex (FLEX) in focus, as its globally integrated supply chain makes trade policy shifts especially relevant for investors. See our latest analysis for Flex. That tariff-related 3.4% share price drop came against a much stronger backdrop for Flex, with a 90 day share price return of 15.33% and a 1 year total shareholder return of 62.74%. This suggests momentum has been firmly positive despite short...

Blackstone (NYSE:BX) has agreed to acquire Champions Group, a multi-service home services platform. Blackstone Infrastructure has received Federal Energy Regulatory Commission approval for its planned acquisition of TXNM Energy. Both moves expand Blackstone’s presence in essential services and energy infrastructure businesses. For you as an investor, these updates highlight how Blackstone is putting capital to work in areas tied to everyday needs, from home services to energy transmission...

If you are wondering whether American Express shares still offer value after a strong multi year run, this article will walk through what the current price could mean for long term investors. The stock last closed at US$346.18, with returns of 2.6% over 7 days, a 4.3% decline over 30 days, a 7.1% decline year to date, an 18.4% return over 1 year and a 106.0% return over 3 years, while the 5 year return sits at 171.9%. Recent headlines have focused on American Express as a key player in...

Earlier this week, Markel Group’s insurance operations announced a collaboration with cyber risk specialist Upfort to offer eligible U.S. cyber policyholders access to Upfort Shield, an AI‑powered, multi‑layer defense platform and endpoint detection tools aimed at helping reduce cyberattack risks. This move deepens Markel’s service offering in cyber insurance by pairing coverage with embedded risk‑prevention technology for middle‑market businesses, potentially strengthening customer...

Akamai Technologies recently reported fourth-quarter 2025 results showing revenue of US$1,094.91 million and full-year 2025 revenue of US$4,208.18 million, alongside lower net income and earnings per share compared with the prior year. At the same time, the company issued 2026 guidance calling for higher capital spending and projecting revenue of US$1,060 million to US$1,085 million for the first quarter and US$4.40 billion to US$4.55 billion for the full year, as it invests heavily in its...

Toast stock triggered overview Toast (TOST) has drawn fresh attention after recent trading left the shares with a return of about a 20% decline over the past month and roughly a 19% decline over the past 3 months. See our latest analysis for Toast. At a share price of US$27.07, Toast’s recent momentum looks weak, with a 30 day share price return of about a 20% decline and a year to date share price return of roughly a 20% decline, while the three year total shareholder return of about 39%...

Henry Schein (HSIC) heads into its upcoming quarterly earnings report with heightened attention, as investors weigh the company’s ability to meet consensus expectations and interpret the impact of a recent analyst upgrade on sentiment. See our latest analysis for Henry Schein. Recent trading has been gradually positive, with a 1-day share price return of 3.61% at a latest share price of $79.57 and a 90-day share price return of 6.86%. The 5-year total shareholder return of 28.65% contrasts...

e.l.f. Beauty (ELF) shares moved after the company reported quarterly results that topped expectations and raised its full year outlook, helped by the Rhode acquisition and a record UK launch. See our latest analysis for e.l.f. Beauty. The latest jump around the quarterly results comes on top of a 15.36% 7 day share price return and a 31.96% 90 day share price return. At the same time, the 1 year total shareholder return of 25.49% and very large 5 year total shareholder return suggest...